Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€34.00

€34.00

1.800%
0.6
1.800%
-
 
10.07.25 / Tradegate WKN: A3DMHS / Symbol: GSK / Name: GSK / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

GSK plc ADR Stock

There is an upward development for GSK plc ADR compared to yesterday, with an increase of €0.60 (1.800%).
So far the community has only identified positive things for GSK plc ADR stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of GSK plc ADR in the next few years

Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of GSK plc ADR vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
GSK plc ADR 1.800% 4.294% -6.077% -5.028% 3.659% -34.928% -23.164%
Astrazeneca ADR 2.480% 3.361% -5.385% -14.583% -3.906% -6.535% 29.202%
Bayer AG ADR 8.660% 0.730% 6.977% 13.115% 39.113% -51.408% -56.329%
Roche Holding AG ADR 0.320% 0.806% -1.740% 9.492% 5.749% -12.921% -10.061%

Comments

Prediction Buy
Perf. (%) -3.43%
Target price 38.500
Change
Ends at 07.02.26

Hey there! I've been keeping an eye on GSK plc ADR, and I gotta say, it's looking pretty interesting right now. With RFK Jr. potentially heading up HHS, we're in for a wild ride in the biotech world. It's like we're about to shake up a snow globe and see where all the flakes land, you know? While this might create some short-term turbulence, I think GSK's solid fundamentals and diverse portfolio could help it weather the storm and even come out stronger. It's like they're a sturdy ship in choppy waters - they might get rocked a bit, but they're built to last. Plus, at the current price, it feels like we're getting a decent deal. What do you think? Could this be a chance to grab a quality pharma stock at a discount before it potentially climbs higher?
Show more

GSK plc (NYSE: GSK) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat
Show more

GSK plc (NYSE: GSK) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for GSK provided by MarketBeat
Show more